Blood RNA biomarker panel detects both left- and right-sided colorectal neoplasms: A case-control study

Journal of Experimental and Clinical Cancer Research

Volumn 32, Issue 1, 2013, Pages

  Chao, Samuel ^a   Ying, Jay ^a   Liew, Gailina ^a   Marshall, Wayne ^a,b   Liew, Choong Chin ^a   Burakoff, Robert ^c  

^a Gene News   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Biomarkers; Blood gene expression; Colonoscopy; Colorectal cancer; Microarray

Indexed keywords

MESSENGER RNA; RNA; TUMOR MARKER;

ADULT; ANXA3 GENE; ARTICLE; CANCER STAGING; CASE CONTROL STUDY; CLEC4D GENE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; HUMAN; IL2RB GENE; LMNB1 GENE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRRG4 GENE; SENSITIVITY AND SPECIFICITY; TNFAIP6 GENE; VNN1 GENE; BLOOD; COLORECTAL TUMOR; EARLY DIAGNOSIS; GENETICS; REPRODUCIBILITY; COLORECTAL NEOPLASMS;

CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS; RNA; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84880334742     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-32-44     Document Type: Article

References (27)

1. American Cancer Society: Cancer facts and figures 2013. [http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf].
2. Canadian Cancer Society: Colorectal cancer statistics. [http://www.cancer.ca/en/cancer-information/cancer-type/colorectal/statistics/?region=on].
3. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF, Ackroyd F, Shike M, Kurtz RC, Hornsby-Lewis L, Gerdes H, Stewart ET, National Polyp Study Workgroup: Prevention of colorectal cancer by colonoscopic polypectomy. N Eng J Med 1993, 329:1977-1981.
4. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L: Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009, 150:1-8.
5. Singh H, Nugent Z, Demers AA, Kliewer EV, Mahmud SM, Bernstein CN: The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterol 2010, 139:1128-1137.
6. Brenner H, Hoffmeister M, Arndt V, Stegmaier C, Altenhofen L, Haug U: Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst 2010, 102:89-95.
7. Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M: Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med 2011, 154:22-30.
8. Soetikno RM, Kaltenbach T, Rouse RV, Park W, Maheshwari A, Sato T, Matsui S, Friedland S: Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA 2008, 299:1027-1035.
9. Azzoni C, Bottarelli L, Campanini N, Di Cola G, Bader G, Mazzeo A, Salvemini C, Morari S, Di Mauro D, Donadei E, Roncoroni L, Bordi C, Sarli L: Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. Int J Colorect Dis 2007, 22:115-126.
10. Marshall KW, Mohr S, Khettabi FE, Nossova N, Chao S, Bao W, Ma J, Li XJ, Liew CC: Blood-based biomarker panel for stratifying current risk for colorectal cancer. Int J Cancer 2010, 126:1177-1186.
11. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M (Eds): AJCC cancer staging manual. 6th edition. New York: Springer; 2002.
12. Vanburen P, Ma J, Chao S, Mueller E, Schneider DJ, Liew CC: Blood gene expression signatures associate with heart failure outcomes. Physiol Genomics 2011, 43:392-397.
13. Burakoff R, Hande S, Ma J, Banks PA, Friedman S, Makrauer F, Liew CC: Differential regulation of peripheral leukocyte genes in patients with active Crohn's disease and Crohn's disease in remission. J Clin Gastroenterol 2010, 44:120-126.
14. Burakoff R, Chao S, Perencevich M, Ying J, Friedman S, Makrauer F, Odze R, Khurana H, Liew CC: Blood-based biomarkers can differentiate ulcerative colitis from Crohn's disease and noninflammatory diarrhea. Inflamm Bowel Dis 2011, 17:1719-1725.
15. Tsuang MT, Nossova N, Yager T, Tsuang MM, Guo SC, Shyu KG, Glatt SJ, Liew CC: Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 2005, 133B:1-5.
16. Glatt SJ, Everall IP, Kremen WS, Corbeil J, Sásik R, Khanlou N, Han M, Liew CC, Tsuang MT: Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proc Natl Acad Sci USA 2005, 102:15533-15538.
17. Glatt SJ, Stone WS, Nossova N, Liew CC, Seidman LJ, Tsuang MT: Similarities and differences in peripheral blood gene-expression signatures of individuals with schizophrenia and their first-degree biological relatives. Am J Med Genet B Neuropsychiatr Genet 2011, 156B:869-887.
18. Osman I, Bajorin DF, Sun TT, Zhong H, Douglas D, Scattergood J, Zheng R, Han M, Marshall KW, Liew CC: Novel blood biomarkers of human urinary bladder cancer. Clin Cancer Res 2006, 12:3374-3380.
19. Liong ML, Lim CR, Yang H, Chao S, Bong CW, Leong WS, Das PK, Loh CS, Lau BE, Yu CG, Ooi EJJ, Nam RK, Allen PD, Steele GS, Wassmann K, Richie JP, Liew CC: Blood-based biomarkers of aggressive prostate cancer. PLoS One 2012, 7:e45802.
20. Zaatar AM, Lim CR, Bong CW, Lee MML, Ooi JJ, Suria D, Raman R, Chao S, Yang H, Neoh SB, Liew CC: Whole blood transcriptome correlates with treatment response in nasopharyngeal carcinoma. J Exp Clin Cancer Research 2012, 31:76.
21. von Wagner C, Good A, Smith SG, Wardle J: Responses to procedural information about colorectal cancer screening using faecal occult blood testing: the role of consideration of future consequences. Health Expect 2011, 15:176-186.
22. de Wijkerslooth TR, de Haan MC, Stoop EM, Bossuyt PM, Thomeer M, van Leerdam ME, Essink-Bot ML, Fockens P, Kuipers EJ, Stoker J, Dekker E: Reasons for participation and nonparticipation in colorectal cancer screening: a randomized trial of colonoscopy and CT colonography. Am J Gastroenterol 2012, 107:1777-1783.
23. Klabunde CN, Vernon SW, Nadel MR, Breen N, Seeff LC, Brown ML: Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults. Medical Care 2005, 43:939-944.
24. Vernon SW: Participation in colorectal screening: a review. JNCI 1997, 89:1406-1422.
25. Worthley DL, Cole SR, Esterman A, Mehaffy S, Roosa NM, Smith A, Turnbull D, Young GP: Screening for colorectal cancer by faecal occult blood test: why people choose to refuse. Intern Med J 2006, 36:607-610.
26. Lewis SF, Jensen NM: Screening sigmoidoscopy. Factors associated with utilization. J Gen Intern Med 1996, 11:542-544.
27. Colorectal Association of Canada: Screening and diagnostics. A guide to screening tests. [http://www.colorectal-cancer.ca/en/screening/screening-tests].